Pain Prevalence After Cesarean Section in Siriraj Hospital

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02810639

Recruitment Status : Completed

First Posted : June 23, 2016

Last Update Posted : June 23, 2016

Sponsor:

Information provided by (Responsible Party):

Sirilak Suksompong, Mahidol University

Tracking Information

First Submitted Date

June 17, 2016

First Posted Date

June 23, 2016

Last Update Posted Date

June 23, 2016

Study Start Date

March 2013

Actual Primary Completion Date

June 2013 (Final data collection date for primary outcome measure)

Current Primary Outcome Measures

Number of patients who have moderate to severe pain after Cesarean section [ Time Frame: 24-48 hours ]

Number of patients who have moderate to severe pain after Cesarean section

Original Primary Outcome Measures

Same as current

Change History

No Changes Posted

Current Secondary Outcome Measures

Not Provided

Original Secondary Outcome Measures

Not Provided

Current Other Pre-specified Outcome Measures

Not Provided

Original Other Pre-specified Outcome Measures

Not Provided

Descriptive Information

Brief Title

Pain Prevalence After Cesarean Section in Siriraj Hospital

Official Title

Pain Prevalence After Cesarean Section in Siriraj Hospital

Brief Summary

Spinal morphine has been widely provided for acute postoperative analgesia. However, the analgesic effect of spinal morphine usually last 12-24 hours. Therefore the investigators are interested in the pain characteristics during the 2nd postoperative day. The investigators will also explore the regimens for pain therapy in our hospital.

Detailed Description

Not Provided

Study Type

Observational

Study Design

Observational Model: Cohort
Time Perspective: Prospective

Target Follow-Up Duration

Not Provided

Biospecimen

Not Provided

Sampling Method

Non-Probability Sample

Study Population

Patients undergoing Cesarean section

Condition

Pain, Postoperative

Intervention

Not Provided

Study Groups/Cohorts

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status

Completed

Actual Enrollment

297

Original Actual Enrollment

Same as current

Actual Study Completion Date

June 2013

Actual Primary Completion Date

June 2013 (Final data collection date for primary outcome measure)

Eligibility Criteria

Inclusion Criteria:

Patients undergoing Cesarean section

Exclusion Criteria:

History of drug addict

Sex/Gender

Sexes Eligible for Study:

Female

Ages

18 Years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Contacts

Contact information is only displayed when the study is recruiting subjects

Listed Location Countries

Thailand

Removed Location Countries

Administrative Information

NCT Number

NCT02810639

Other Study ID Numbers

816/2554(EC3)

Has Data Monitoring Committee

U.S. FDA-regulated Product

Not Provided

IPD Sharing Statement

Plan to Share IPD:

Responsible Party

Sirilak Suksompong, Mahidol University

Study Sponsor

Mahidol University

Collaborators

Not Provided

Investigators

Principal Investigator:

Sirilak Suksompong, MD

Mahidol University

PRS Account

Mahidol University

Verification Date

June 2016

To Top